Volume 3, Issue 1 (Winter 2022)                   J Vessel Circ 2022, 3(1): 1-6 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Salimi A, Vahdian M, Madani S, Derakhshani M, Farasat E, Karimi Matloub R, et al . Examining the Frequency of Port Catheter Complications and the Duration of Its Performance Associated with the Length of the Catheter in Patients with Port Placement. J Vessel Circ 2022; 3 (1) :1-6
URL: http://jvessels.muq.ac.ir/article-1-231-en.html
1- Department of Surgery, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
2- Department of Social and Family Medicine, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Department of Anesthesia, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran
4- Department of Pediatrics, FDepartment of Pediatrics, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iranaculty of Medicine, Qom University of Medical Sciences, Qom, Iran
5- Vice Chancellor of Education, Qom University of Medical Sciences, Qom, Iran.
6- Department of Pediatrics, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
Abstract:   (707 Views)
Background and Aim: Considering that the use of port catheters in long-term treatments and the quality of life (QoL) of patients with special conditions, including children, is particularly important, we decided to investigate the effect of the length of the port catheter on the duration of its performance in children.
Materials and Methods: All the files of patients referred to the Surgery Department of Hazrat Masoumeh (PBUH) hospital, who underwent catheterization, were examined by observing the inclusion and exclusion criteria. The inclusion criteria included patients aged 14 years or younger with proven acute leukemia and the need for long-term intravenous access, survival of more than one week at the time of the patient’s entry into the study, and undergoing aggressive chemotherapy. The exclusion criteria included any contraindication to surgery or local anesthesia, sensitivity to lidocaine or anesthetics, evidence of any contraindication to using a subcutaneous catheter, clinical superior vena cava syndrome, and any mass or anatomical anomaly. A pediatric surgeon performed all ports. In the last stage, all the information related to the research was extracted from the existing files of these patients and analyzed with SPSS software, version 22.
Results: In this study, the infection rate was 4(3.3%), bacteremia rate 5(4.2%), and thrombosis 13(10.8%). No statistically significant relationship was observed between the frequency of catheter port complications (infection, bacteremia, and thrombosis) with the gender of the patients or the catheter length. Furthermore, it was found that with the increase in the length of the catheter port, the time of complications also increased, and this increase was statistically significant.
Conclusion: Considering the complications of catheter port, the correct way to use and how to take care of the catheter during the treatment of patients should be optimally done.
Full-Text [PDF 772 kb]   (337 Downloads) |   |   Full-Text (HTML)  (236 Views)  
Type of Study: Research | Subject: vascular surgery
Received: 2022/07/8 | Accepted: 2022/08/31 | Published: 2022/08/1

References
1. Lorch H, Zwaan M, Kagel C, Weiss HD. Central venous access ports placed by interventional radiologists: Experience with 125 consecutive patients. Cardiovasc Intervent Radiol. 2001; 24(3):180-4. [DOI:10.1007/s002700001721] [PMID] [DOI:10.1007/s002700001721]
2. Teichgräber UK, Pfitzmann R, Hofmann HA. Central venous port systems as an integral part of chemotherapy. Dtsch Arztebl Int. 2011; 108(9):147-53. [DOI:10.3238/arztebl.2011.0147] [DOI:10.3238/arztebl.2011.0147]
3. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. Dtsch Arztebl Int. 2008; 58(6):323-46. [DOI:10.3322/CA.2008.0015] [PMID] [DOI:10.3322/CA.2008.0015]
4. Kucher N. Deep-vein thrombosis of the upper extremities. N Engl J Med. 2011; 364(9):861-9. [DOI:10.1056/NEJMcp1008740] [PMID] [DOI:10.1056/NEJMcp1008740]
5. Allers M, Timoumi L, Kirk AT, Schlottmann F, Zimmermann S. Coupling of a high-resolution ambient pressure drift tube ion mobility spectrometer to a commercial time-of-flight mass spectrometer. J Am Soc Mass Spectrom. 2018; 29(11):2208-17. [DOI:10.1007/s13361-018-2045-4] [PMID] [DOI:10.1007/s13361-018-2045-4]
6. Plumb A, Murphy G. The use of central venous catheters for intravenous contrast injection for CT examinations. Br J Radiol. 2011; 84(999):197-203. [DOI:10.1259/bjr/26062221] [PMID] [PMCID] [DOI:10.1259/bjr/26062221]
7. Ljung R, Petrini P, Lindgren AK, Berntorp E. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia. Acta Paediatr. 1992; 81(11):918-20. [DOI:10.1111/j.1651-2227.1992.tb12135.x] [PMID] [DOI:10.1111/j.1651-2227.1992.tb12135.x]
8. Arzanian M, Shamsian BS, Eshghi P, Kajiyazdi M, Alavi S, Nazari S, et al. [The clinical application of port a cath in the hematology-oncology patients (Persian)]. Sci J Iran Blood Transfus Organ. 2015; 12(1):85-99. [Link]
9. Rouzrokh M, Shamsian BS, Khalegh Nejad Tabari A, Mahmoodi M, Kouranlo J, Manafzadeh G, et al. Totally implantable subpectoral vs. subcutaneous port systems in children with malignant diseases. Arch Iran Med. 2009; 12(4):389-94. . [PMID]
10. Weigand K, Encke J, Meyer FJ, Hinkel UP, Munder M, Stremmel W, et al. Low levels of prothrombin time (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters. Med Klin. 2009; 104(5):331-5. [DOI:10.1007/s00063-009-1070-2] [PMID] [DOI:10.1007/s00063-009-1070-2]
11. Carr E, Jayabose S, Stringel G, Slim M, Ozkaynak MF, Tugal O, et al. The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2006; 47(7):886-8. [DOI:10.1002/pbc.20629] [PMID] [DOI:10.1002/pbc.20629]
12. Tabatabaie O, Kasumova GG, Kent TS, Eskander MF, Fadayomi AB, Ng SC, et al. Upper extremity deep venous thrombosis after port insertion: What are the risk factors? Surgery. 2017; 162(2):437-44. [DOI:10.1016/j.surg.2017.02.020] [PMID] [DOI:10.1016/j.surg.2017.02.020]
13. Aribas B, Uylar T, Aksoy M, Turker I, Yildiz F, Tiken R, et al. Factors on patency periods of subcutaneous central venous port: Long-term results of 1,408 patients. Cancer Imaging. 2015; 15(Suppl 1):P27. [PMCID] [DOI:10.1186/1470-7330-15-S1-P27]
14. Jonczyk M, Gebauer B, Rotzinger R, Schnapauff D, Hamm B, Collettini F. Totally implantable central venous port catheters: Radiation exposure as a function of puncture site and operator experience. In Vivo. 2018; 32(1):179-84. [DOI:10.21873/invivo.11222] [PMID] [PMCID] [DOI:10.21873/invivo.11222]
15. Li W, Xu R, Fan D. Clinical application of electrocardiogram-guided tip positioning in peripheral inserted central catheters placement. J Cancer Res Ther. 2018; 14(4):887. [DOI:10.4103/jcrt.JCRT_46_18] [PMID] [DOI:10.4103/jcrt.JCRT_46_18]
16. Alfonso Alvarez-Rodríguez J, García-Suárez M, Fernández-García D, Méndez-Martínez C, Gómez-Salgado J. Analysis of peripheral central venous access ports at the forearm: An observational study. Eur J Cancer Care. 2018; 27(6):e12929.[DOI:10.1111/ecc.12929] [PMID] [DOI:10.1111/ecc.12929]
17. Borgmeyer S. [Short- and longterm outcome of central venous access port devices implanted at the forearm by interventional radiologists (German) [PhD dissertation]. Munich: Technische Universität München; 2017. [Link]
18. Richter MJ, Ewert R, Warnke C, Gall H, Classen S, Grimminger F, et al. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension. Clin Res Cardiol. 2017; 106(3):174-82. [DOI:10.1007/s00392-016-1037-2] [PMID] [DOI:10.1007/s00392-016-1037-2]
19. Salimi A, Mollaabassi F, Rezvan S, Noori E, Naderi A, Kalhor N, et al. Comparative study of porting complications by implantation under and on the pectoral muscle in cancer patients at Shahid Beheshti and Hazrat Masoumeh hospitals during the years 2010-2014. Iran J Pediatr Surg. 2020; 6(2):92-9. [DOI:10.22037/irjps.v6i2.31211]
20. Kachoei A, Rafiei M, Noori E, Salahi S, Shater M. Catheter fixation behind the urachus: A novel laparoscopic technique to revise malfunctioning peritoneal dialysis catheters. Surgery Curr Res. 2018; 8(2):1000315. [DOI:10.4172/2161-1076.1000315] [DOI:10.4172/2161-1076.1000315]
21. Mermel LA, Alang N. Adverse effects associated with ethanol catheter lock solutions: A systematic review. J Antimicrob Chemother. 2014; 69(10):2611-9. [DOI:10.1093/jac/dku182] [PMID] [DOI:10.1093/jac/dku182]
22. Zakhour R, Chaftari AM, Raad II. Catheter-related infections in patients with haematological malignancies: Novel preventive and therapeutic strategies. Lancet Infect Dis. 2016; 16(11):e241-50. [DOI:10.1016/S1473-3099(16)30213-4] [PMID] [DOI:10.1016/S1473-3099(16)30213-4]
23. Bassirian M, Salimi A, Noori E, Moeini Z. The impact of taurolock versus heparin lock for the maintenance of central vein catheters patency in pediatric tertiary care hospitals. J Vessels Circ. 2020; 1(4):7-12. [DOI:10.52547/jvesselcirc.1.4.7] [DOI:10.52547/jvesselcirc.1.4.7]
24. Mehrzad V, Eshaghian A, Beigi AA. An evaluation on complications and patient satisfaction of port catheter in patients with acute leukemia in Alzahra and Milad hospitals, Isfahan, Iran: A one-year prospective analysis. J Isfahan Med Sch. 2018; 36(473):309-16. [DOI:10.22122/JIMS.V36I473.5365]
25. Sarris GE, Kirvassilis G, Zavaropoulos P, Belli E, Berggren H, Carrel T, et al. Surgery for complications of trans-catheter closure of atrial septal defects: A multi-institutional study from the European congenital heart surgeons association. Eur J Cardiothorac Surg. 2010; 37(6):1285-90. [DOI:10.1016/j.ejcts.2009.12.021] [PMID] [DOI:10.1016/j.ejcts.2009.12.021]
26. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler F. Implantable vascular access systems: Experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998; 22(1):12-6. [DOI:10.1007/s002689900342] [PMID] [DOI:10.1007/s002689900342]
27. Choi YH, Cheon JE, Shin SH, Shin SM, Lee SM, Cho HH, et al. Optimal insertion lengths of right and left internal jugular central venous catheters in children. Pediatr Radiol. 2015; 45(8):1206-11. [DOI:10.1007/s00247-015-3289-9] [PMID] [DOI:10.1007/s00247-015-3289-9]
28. Surov A, Buerke M, John E, Kösling S, Spielmann RP, Behrmann C. Intravenous port catheter embolization: Mechanisms, clinical features, and management. Angiology. 2008; 59(1):90-7. [DOI:10.1177/0003319707303883] [PMID] [DOI:10.1177/0003319707303883]

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Vessels and Circulation

Designed & Developed by : Yektaweb